A meta2cell enriched in patients with COVID-19 approximately 10 days after symptom onset (metacell B) comprises Foxp3+ Treg cells expressing the chemokine receptor gene CCR10, suggesting recruitment to the inflamed lung or mucosal epithelium and a role in regulating inflammation54 (Fig. 6e). This evidence concerns the gene CCR10 and COVID-19.